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Abstract 
A family of prototype 2D monolithic silicon-diode array detectors (MP512, Duo, Octa) has been proposed 
by the Centre for Medical Radiation Physics, University of Wollongong (Australia) for relative dosimetry in 
small megavoltage photon beams. These detectors, which differ in the topology of their 512 sensitive 
volumes, were originally fabricated on bulk p-type substrates. More recently, they have also been 
fabricated on epitaxial p-type substrates. In the literature, their performance has been individually 
characterized for quality assurance (QA) applications. The present study directly assessed and compared 
that of a MP512-bulk and that of a MP512-epitaxial in terms of radiation hardness, long-term stability, 
response linearity with dose, dose per pulse and angular dependence. Their measurements of output 
factors, off-axis ratios and percentage depth doses in square radiation fields collimated by the jaws and 
produced by 6 MV and 10 MV flattened photon beams were then benchmarked against those by 
commercially available detectors. The present investigation was aimed at establishing, from a medical 
physicist's perspective, how the bulk and epitaxial fabrication technologies would affect the 
implementation of the MP512s into a QA protocol. Based on results, the MP512-epitaxial would offer 
superior radiation hardness, long-term stability and achievable uniformity and reproducibility of the 
response across the 2D active area. 
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A family of prototype 2D monolithic silicon-diode array detectors (MP512, Duo, Octa) has been proposed by the Centre for 18 
Medical Radiation Physics, University of Wollongong (Australia) for relative dosimetry in small megavoltage photon beams. 19 
These detectors, which differ in the topology of their 512 sensitive volumes, were originally fabricated on bulk p-type substrates. 20 
More recently, they have also been fabricated on epitaxial p-type substrates. In the literature, their performance has been 21 
individually characterized for quality assurance applications. The present study directly assessed and compared that of a MP512-22 
bulk and that of a MP512-epitaxial in terms of radiation hardness, long-term stability, response linearity with dose, dose per 23 
pulse and angular dependence. Their measurements of output factors, off-axis ratios and percentage depth doses in square 24 
radiation fields collimated by the jaws and produced by 6 MV and 10 MV flattened photon beams were then benchmarked against 25 
those by commercially available detectors. The present investigation was aimed at establishing, from a medical physicist's 26 
perspective, how the bulk and epitaxial fabrication technologies would affect the implementation of the MP512s into a quality 27 
assurance protocol. Based on results, the MP512-epitaxial would offer superior radiation hardness, long-term stability and 28 
achievable uniformity and reproducibility of the response across the 2D active area. 29 
 30 
Key words: dosimetry, 2D monolithic silicon-diode array detector, epitaxial silicon, megavoltage photon beam 31 
 32 
1. Introduction 33 
The Centre for Medical Radiation Physics (CMRP), University of Wollongong (Australia) has designed a range of silicon-34 
detector prototypes dedicated to quality assurance (QA) applications in megavoltage (MV) photon beams delivered with medical 35 
linear accelerators (linacs) [1], [2]. Among these, it has proposed and characterized three 2D monolithic silicon-diode arrays (the 36 








Figure 1. 2D monolithic silicon-
diode array detectors proposed 
by the CMRP for QA in MV 
photon beams: (a) the MP512, 
(b) the Duo and (c) the Octa. 
 39 
The MP512 has SVs (0.5 × 0.5 mm2) uniformly distributed over a square active area (52 × 52 mm2) with a pitch of 2 mm. 40 
The Duo has SVs (0.04 × 0.8 mm2) arranged along two linear arrays with a pitch of 0.2 mm to offer an improved resolution 41 
which would be of interest for measurements in small radiation fields (≤ 1 cm across). A compromise between the coarse 42 
resolution of the MP512 and the limited 2D dose map characterization of the Duo would be offered by the Octa. It has SVs 43 
(0.04 × 0.8 mm2) arranged along four linear arrays at 45° relative to each other with a pitch of 0.3 mm along the vertical and 44 
horizontal arrays and of 0.43 mm along the two diagonals. 45 
These devices, operated in passive mode (no external bias applied), have a high temporal resolution of the read-out electronics 46 
(pulse-by-pulse acquisition) [3] which makes them attractive for applications in dynamic stereotactic treatment modalities. They 47 
were devised for in-phantom measurements. As such,  they are sandwiched between two 5 mm thick PMMA slabs, with the 48 
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2 
upper one having a small recess or air gap [4] on top of the SVs to minimize [5] the corrections required to account for the field 49 
size-dependent response of these silicon-based detectors in small MV photon beams [6]. 50 
The detectors were originally fabricated on a bulk p-type silicon-wafer Czochralski [7] substrate (resistivity of 10 Ωcm) and 51 
pre-irradiated to stabilize their response with accumulated dose [8]. More recently, the same devices have also been fabricated on 52 
a radiation-hard p-type epitaxial [9] layer (resistivity of 100 Ωcm), grown onto a thick heavily-doped silicon substrate (resistivity 53 
of 0.001 Ωcm). The thin active epitaxial layer has the required mechanical strength over large areas. These epitaxial devices may 54 
have improved radiation hardness and may not require pre-irradiation for sensitivity stabilization [10], [11]. 55 
In the literature, the performances of the MP512-bulk [12], [13], the MP512-epitaxial [14], the Duo-bulk [15], the Duo-56 
epitaxial [16] and the Octa-epitaxial [17], [18] have been individually characterized for machine-specific and patient-specific 57 
QA. Machine QA describes procedures intended to verify the dosimetric parameters of a linac, such as its output factor. Patient 58 
QA, also referred to as pre-treatment QA, describes procedures to verify clinical plans. There is, however, a lack of a direct and 59 
thorough comparison of how the bulk and epitaxial fabrication technologies would affect the implementation of these devices 60 
into a QA protocol. Aiming at answering this question, the present study evaluated and compared, from a medical physicist's 61 
perspective, the performance of a MP512-bulk and of a MP512-epitaxial.  62 
 63 
2. Materials and methods 64 
2.1. Dosimeters and participating facilities 65 
Along with the MP512-bulk and the MP512-epitaxial prototypes, the present study considered as benchmark measurements, 66 
under the same experimental conditions, by multiple alternative detectors: Gafchromic™ EBT3 films (Ashland Inc., USA), 67 
MOSkin™ detectors and three different ionization chambers (Table 1). 68 
Films were scanned with a Microtrex ScanMaker i800 flatbed scanner using a 48-bit RGB and a resolution of 72 dpi. All 69 
films were pre- and post-scanned six times using only the last three optical density maps, maintaining a consistent orientation. 70 
The film analysis methodology was the same as that used by Aldosari et al. [12].  71 
MOSkinTM are metal-oxide-semiconductor field-effect transistor (MOSFET) -based devices developed for real-time in vivo 72 
dose measurements. Their SV consists of a 0.55 µm thick SiO2 layer, on top of a silicon substrate, mounted underneath a thin 73 
plastic layer with a uniform thickness of 0.07 mm. As such, they provide a skin-equivalent depth-dose when placed on a surface 74 
[19], [20].  75 
The ionization chambers used were a CC13 (IBA Dosimetry, Germany), a Farmer chamber type NE2571A used with a 76 
UNIDOS electrometer (PTW, Germany) with a supply voltage of +300 V, and a Markus chamber model N23343 (PTW, 77 
Germany). 78 
 79 
Table 1. Description of benchmarking detectors considered for each test in the present study. 80 
Benchmarking detectors Test 
films Angular dependence, output factors, off-axis ratios 
MOSkinTM Output factors 
CC13 chamber Percentage depth dose 
Farmer chamber Dose per pulse dependence 
Markus chamber Percentage depth dose 
 81 
Experimental measurements for radiation hardness investigation were performed at the Gamma Technology Research 82 
Irradiator (GATRI) facility at the Australian Nuclear Science and Technology Organisation (ANSTO, Lucas Heights, NSW, 83 
Australia). Investigations of long-term stability, response linearity with dose, dose per pulse dependence, angular dependence 84 
and measurements described in the clinical application section were performed at the Illawarra Cancer Care Centre (ICCC, 85 
Wollongong, NSW, Australia) using a Varian Clinac® iX (Varian Medical System, Palo Alto, CA, USA) medical linac. The 86 
linac operated with a pulse frequency of 360 Hz and was calibrated to deliver 1 cGy/MU at dmax in water at 100 cm source-to-87 
surface distance (SSD). 88 
2.2. Radiation hardness, long-term stability and response linearity with dose 89 
Investigation of radiation hardness was performed by irradiating the MP512s with a dose rate 2.28 kGy/hr using a Co-60 90 
gamma source. The MP512-bulk was irradiated with a total water-equivalent dose of 80 kGy, with response stability assessed 91 
after dose increments of 10 kGy. The MP512-epi was irradiated with a total water-equivalent dose of 140 kGy, with response 92 
stability assessed after dose increments of 20 kGy or 40 kGy. Response stability assessments were performed by irradiating the 93 
devices, at 1.5 cm depth in solid water phantom, 100 cm SSD, with a 10 cm side square field collimated by the jaws and 94 
produced by a 6 MV photon beam. Each measurement was repeated 5 times to minimize random uncertainties, and only the 95 
average response of the 4 central SVs was considered. 96 
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3 
Investigation of long-term stability after pre-irradiation was performed by considering the response variation of the MP512s 97 
over 12 months. Assessments, made at 1 month intervals, were done by irradiating the devices, at 1.5 cm depth in solid water 98 
phantom, 100 cm SSD, with a 10 cm side square field collimated by the jaws and produced by a 6 MV photon beam. 99 
Accumulated total dose was 500 Gy, while each measurement had a delivered dose of 100 monitor units (MU) at 600 MU/min. 100 
Only the average response of the 4 central SVs was considered. 101 
Investigation of response linearity was done in the range from 1 MU to 500 MU. The test was performed by irradiating the 102 
MP512s, at 1.5 cm depth in solid water phantom, 100 cm SSD, with a 10 cm side square field collimated by the jaws and 103 
produced by 6 MV and by 10 MV photon beams. 104 
2.3. Dose per pulse dependence 105 
Investigation of the dose per pulse dependence of the response of the MP512s was performed by irradiating the devices, at 106 
1.5 cm depth in solid water phantom, with a 10 cm side square field collimated by the jaws and produced by a 6 MV photon 107 
beam. The devices were irradiated by a fixed number of MU, changing the SSD in the range of 100 cm to 370 cm to change the 108 
dose per pulse at the detector location [12], [21]. Doses per pulse in the range from 0.01 mGy/pulse to 0.34 mGy/pulse were 109 
considered. Each measurement was repeated 5 times to minimize random uncertainties. 110 





with Q the average charge collected by their 4 central SVs and QIC the charge collected by the ionization chamber used as 113 





with SSSD=ref the sensitivity SSSD at the reference dose per pulse of 0.278 mGy/pulse. 116 
2.4. Angular dependence 117 
Investigation of the angularly-dependent response was performed by irradiating the MP512s, lodged into a cylindrical PMMA 118 
phantom, with a 10 cm side square field collimated by the jaws and produced by 6 MV and 10 MV photon beams. The radiation-119 
beam incidence angle θ was changed in the range from 0° to 180° in 10° steps, irradiating the MP512s at each step 5 times with 120 
100 MU at 600 MU/min. Films were used as reference assuming their response is angular independent [22], although this has 121 
recently been disputed [23]. 122 
The investigation procedure, described also by Stansook et al. [24], starts with defining, for each SV of the MP512s, a 123 










with θ = 0° the incidence angle for which the beam was perpendicular to the 2D active surface of the MP512s. Only the average 128 
response of the 4 central SVs was considered. 129 
2.5. Clinical application 130 
As a clinical application, we considered measurements relevant to machine-specific QA, such as output factors (OFs), off-axis 131 
ratios (OARs) and percentage depth doses (PDDs).  132 
Prior to all measurements, the MP512s were aligned with respect to the machine central axis (CAX) by maximizing the 133 
response of their central SVs using the smallest available square field (0.5 cm side). Each measurement was repeated 3 times to 134 
minimize random uncertainties. 135 
For OFs, the MP512s, at 10 cm depth in solid water phantom, 90 cm SSD, were irradiated with square fields in the range 136 
from 0.5 cm to 10 cm side collimated by the jaws and produced by 6 MV and 10 MV photon beams.  137 
For OARs, the MP512s, at 10 cm depth in solid water phantom, 90 cm SSD, were irradiated with square fields in the range 138 
from 1 cm to 4 cm side collimated with the jaws and produced by a 6 MV photon beam. For a quantitative estimation of full-139 
width half-maximum (FWHM) and penumbra width (taken as the distance between the 80% and the 20% isodose levels), all 140 
OARs were analysed with MATLAB® (MathWorks, Inc., Natick, MA, USA) using a shape-preserving interpolant function.  141 
For PDDs, the MP512s were irradiated in a solid water phantom at depths in the range from 0.5 cm to 30 cm, 100 cm SSD, 142 
by a square field 10 cm side collimated by the jaws and produced by 6 MV and 10 MV photon beams. PDDs by the MP512s 143 
were benchmarked against those by a CC13 chamber for depths in the range from 1.5 cm to 30 cm and those by a Markus 144 
chamber for depths in the range from 0.5 cm to 10 cm. The known dose over-estimation by the Markus chamber was corrected 145 
for by following the Velkley and Rawlinson method [25][26].  146 
 147 
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4 
3. Results 148 
3.1. Radiation hardness, long-term stability and response linearity with dose 149 
Radiation hardness in terms of sensitivity degradation with accumulated dose is in Figure 2 for both MP512s. Sensitivity is 150 
shown normalized to that at zero accumulated dose. Error bars, calculated as 1 standard deviation, did not exceed the symbol 151 
size. Sensitivity of the MP512-bulk was reduced to about 75% of the initial value after 10 kGy, that of the MP512-epitaxial was 152 
approximately 85% of the initial value after 80 kGy. 153 
In terms of long-term stability, the variation in sensitivity was ±10% for the MP512-bulk, after up to 500 Gy delivered by 154 
a 6 MV photon beam over 12 months. It was within ±0.9%, with 2 standard deviations being ±0.03%, for the MP512-epitaxial.  155 
The response of the MP512s was linear in the investigated dose range from 10 to 500 MU (adjusted regression coefficient 156 
R2 = 1.000±0.001). 157 
 158 
 
Figure 2. Sensitivity degradation with accumulated dose of the 
MP512s. Response is shown normalized to that at zero dose. 
Sensitivity of the MP512-bulk was reduced to ~75% of the initial 
value after 10 kGy. Sensitivity of the MP512-epitaxial was reduced to 
~85% of the initial value after 80 kGy. 
3.2. Dose per pulse dependence 159 
The dose per pulse-dependence of the MP512s is in Figure 3. Error bars are 1 standard deviation. Maximum dose per pulse-160 
dependence was approximately 6% at 0.01 mGy/pulse, relative to 0.278 mGy/pulse, for the MP512-bulk. It was 8% at 161 
0.02 mGy/pulse, relative to 0.278 mGy/pulse, for the MP512-epitaxial. 162 
 163 
 
Figure 3. Dose per pulse dependence of the MP512s. Response is 
shown normalized to that at 0.278 mGy/pulse. Maximum dose per 
pulse-dependence was ~6% at 0.01 mGy/pulse for the MP512-bulk. 
It was ~8% at 0.02 mGy/pulse for the MP512-epitaxial. 
3.3. Angular dependence 164 
The angularly-dependent response of the MP512s is in Figure 4 (6 MV beam) and in Figure 5 (10 MV beam). Error bars, 165 
calculated as 2 standard deviations, did not exceed the symbol size. 166 
 167 




Figure 4. 6 MV beam: angularly-dependent response of the 
MP512s. 0° refers to incident-beam direction perpendicular to the 
2D detector plane. Maximum sensitivity degradation was reached 
at incident-beam angle of 90°, i.e. beam direction parallel to the 
2D detector plane. 
Figure 5. 10 MV photon beam: angularly-dependent response of 
the MP512s. Differences seen by comparing the angular 
dependence in a 6 MV and in a 10 MV beam are explained by 
beam quality-dependent perturbations to particle spectra 
introduced by SV and packaging. 
3.4. Clinical application 168 
OFs by the MP512s, films and MOSkinTM are in Figure 6 (6 MV beam) and in Figure 7 (10 MV beam). Percentage differences 169 
are shown in the lower panels.  170 
A cross-plane OAR by the MP512-epitaxial and by film in a square field jaws-defined of 1 cm side is shown in Figure 8 171 
(6 MV beam). In all investigated fields, FWHMs of cross-plane OARs measured by the MP512-epitaxial agreed with those by 172 
films to within 1% in a 6 MV beam and to within 1.5% in a 10 MV beam. All penumbra widths agreed within 0.6 mm.  173 
PDDs by the MP512s, Markus and CC13 chambers are in Figure 9 (6 MV beam) and in Figure 10 (10 MV beam). Differences 174 
between measurements by the MP512s and the chambers were within ±2% at all depths, for both beam energies investigated. 175 
Error bars, calculated as 2 standard deviations, do not exceed the symbol size. 176 
 177 
  
Figure 6. 6 MV beam: OFs by the MP512s, films and MOSkinTM. 
Percentage differences are shown in the lower panel. 
Figure 7. 10 MV beam: OFs by the MP512s, films and MOSkinTM. 
Percentage differences are shown in the lower panel. 
  





Figure 8. 6 MV beam: cross plane OAR in a 1 cm side square field 
by the MP512-epitaxial and by film. 
 
  
Figure 9. 6 MV beam: PDDs by the MP512s, Markus and CC13 
chambers. Percentage differences are shown in the lower panel. 
Figure 10. 10 MV beam: PDDs by the MP512s, Markus and CC13 
chambers. Percentage differences are shown in the lower panel. 
4. Discussion 178 
4.1. Radiation hardness, long-term stability and response linearity with dose 179 
For a bulk device, pre-irradiation is required to stabilize its response with accumulated dose, at the cost of a reduced sensitivity 180 
[8]. In the present work, the sensitivity of the MP512-bulk was heavily reduced to close to 75% of the initial value and stabilized 181 
after irradiation with 20 kGy by a Co-60 gamma photon source, but with a residual sensitivity variation of approximately ±5% 182 
which would call for frequent recalibrations. The sensitivity of the MP512-epitaxial was stabilized within ±3% after 40 kGy and 183 
within ±0.3% after 80 kGy, demonstrating its superior radiation-hardness and making frequent recalibrations optional. Residual 184 
sensitivity was close to 85% of the initial value. These results can be complemented by those on the investigation of the long-185 
term stability of the MP512s after pre-irradiation, adding to the superior performance of the MP512-epitaxial over the MP512-186 
bulk. 187 
The linear response of the MP512s in the investigated dose range from 10 to 500 MU agrees with previous investigations 188 
which have demonstrated that the MP512-bulk [12], the Octa-bulk and the Octa-epitaxial [27] were linear in the dose range 50 to 189 
500 MU. These results suggest that both a bulk and an epitaxial substrate would in principle offer an equivalent performance in 190 
terms of response linearity with delivered dose.   191 
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4.2. Dose per pulse dependence 192 
The dose per pulse of the order of 102 Gy/s under which the detector is operated is much different than the average dose to 193 
water delivered by medical linacs of the order of 4 Gy/min at dmax [1], [28]. For QA applications, the dose per pulse varies with 194 
depth in water, across the radiation field, due to introduction of beam attenuators [29] and, if flattening filter free photon beams 195 
are used, also in the central axis region of a radiation field [30]. The dose per pulse dependence of the response of silicon-based 196 
detectors is well-known, with a decrease in sensitivity expected with decreased dose per pulse, as first reported by Rikner and 197 
Grusell [31]. This dependence affects measurement accuracy and would call for a correction. 198 
Previous studies have investigated the dose per pulse dependence of the MP512, Duo and Octa in a 6 MV beam. The MP512-199 
bulk had a maximum sensitivity degradation of approximately 5% in the range from 0.009 mGy/pulse to 0.34 mGy/pulse with 200 
respect to 0.278 mGy/pulse [12]. The Duo-bulk had sensitivity degradation within 23% at 0.021 mGy/pulse with respect to 201 
0.278 mGy/pulse [15]. The non-preirradiated Octa-epitaxial had a maximum sensitivity degradation of close to 26% at 202 
0.021 mGy/pulse relative to 0.278 mGy/pulse [32].   203 
In the present study, the maximum sensitivity degradations of approximately 6%, MP512-bulk, and 8%, MP512-epitaxial, 204 
found was of the same order of magnitude between the two devices. The degradation was however significantly smaller than that 205 
reported by investigations on the Duo and on the Octa, a result which would merit further investigation. The larger relative 206 
sensitivity degradation of the MP512-epitaxial over the MP512-bulk can be explained by the fact that the dose per pulse 207 
dependence decreases by decreasing the resistivity of the silicon active substrate, or by reducing the minority carrier lifetime by 208 
pre-irradiation [11], [33].   209 
4.3. Angular dependence 210 
The angularly-dependent response of a silicon detector is mainly explained in terms of anisotropy in its materials and 211 
assembly [34]. 212 
In a previous investigation [32], the Octa-bulk had a maximum angular dependence of 30% in the case of a 6 MV beam. The 213 
Octa-epitaxial had a maximum angular dependence of 23% in the case of a 6 MV beam and of 20% in the case of a 10 MV 214 
beam. It was also reported that the MP512-bulk [24] had a maximum angular dependence of 18.5% ± 0.5% in the case of a 215 
6 MV beam and of 15.5% ± 0.5% in the case of a 10 MV beam.  216 
In the present study, results for the MP512-epitaxial were within ±2% of those for the MP512-bulk [24] at all angles. In all 217 
cases, maxima were reached at incident beam angle of 90° i.e. when the beam direction was parallel to the 2D detector plane. In 218 
the range from 0° to 90°, angular dependence increases owing to increasing beam attenuation by the silicon. From 90° to 180°, 219 
angular dependence decreases for the opposite reason. In this case, lower relative values are explained by additional attenuation 220 
owing to the detector packaging. The differences seen by comparing the angular dependence in a 6 MV beam with that in a 221 
10 MV beam are explained by beam quality-dependent perturbations to the particle spectra introduced by the SV and its 222 
packaging [6]. 223 
For application in arc radiotherapy QA, the angularly-dependent response of a detector such as the MP512 can be mitigated by 224 
corrections [14], [24], provided the radiation-beam incidence angle is known at any time. Alternatively, the 2D active surface 225 
could be maintained always perpendicular to the incident beam by using a suitable rotating phantom.  226 
These results, supported by those of a previous investigation [32], suggest that the MP512-bulk and the MP512-epitaxial are 227 
affected by a comparable angularly-dependent response. To minimize uncertainties in the reported dose measurements, however, 228 
the devices would call for correction factors to be measured individually, for each field size and beam quality considered. 229 
4.4. Clinical application 230 
OFs by the MP512s agreed within ±2% with those by films and MOSkinTM, for all square fields investigated in the range 231 
0.5 cm to 10 cm side, for both 6 MV and 10 MV beams.  232 
Considered cross-plane OARs in square fields defined by the jaws in the range 1 cm to 4 cm with a 6 MV beam, it was found 233 
that FWHMs by the MP512-epitaxial agreed within ±1% with those by films, while penumbra widths agreed within 0.6 mm. 234 
These results were consistent with those by the MP512-bulk reported in a previous investigation, in which discrepancies with 235 
respect to results by films were within ±1.2% [12]. In the same radiation fields with a 10 MV beam, FWHMs by the MP512- 236 
epitaxial agreed within ±1.6% with those by films, and penumbra widths agreed within 0.6 mm.   237 
Considering PDDs, differences between measurements by the MP512s and the chambers were within ±2% at all depths, for 238 
both beam energies investigated. Difference between measurements by the MP512-bulk and the MP512-epitaxial were always 239 
within ±2%. 240 
 241 
5. Conclusions 242 
The present study assessed and compared the performance of two prototype detectors, a MP512-bulk and a MP512-epitaxial, 243 
in the context of quality assurance applications in megavoltage photon beams delivered by medical linear accelerators.  244 
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Experimentally, both MP512s showed good linearity with delivered dose. However, the MP512-epitaxial demonstrated a 245 
superior radiation hardness and long-term stability of the response, suggesting pre-irradiation may not be necessary and frequent 246 
recalibrations would be redundant. It was then highlighted that both the MP512s were affected by a dose per pulse and angular 247 
dependence of a similar magnitude, requiring suitable corrections to be assessed individually. Their performance in terms of 248 
typical machine-specific quality assurance measurements, such as output factors, off-axis ratios and percentage depth dose, were 249 
also of comparable accuracy when benchmarked with commercially available detectors.  250 
Based on these results, supported by those reported by previous investigations [27], [32], [35], our conclusion is that, from a 251 
medical physicist’s perspective, the MP512-epitaxial would be the candidate of choice as a quality assurance tool owing to 252 
superior radiation hardness, long-term stability and achievable uniformity and reproducibility of the response of the SVs across a 253 
large 2D active area. We also expect the same conclusion to apply to similar devices (Duo-bulk, Duo-epitaxial and Octa-bulk, 254 
Octa-epitaxial), which differ from the MP512 only in the topology of the sensitive volumes.   255 
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